Macerich Co (FRA:M6G) Research & Development: €0.0 Mil (TTM As of Mar. 2026)


FRA:M6G Macerich Co FRA:M6G
55 GF Score
Price €21.40
GF Value €12.85
! 9 Warning Signs
View Full Analysis

What is Macerich Co Research & Development?

Macerich Co FRA:M6G +5.94% 55 Research & Development is €0.0 Mil as of Mar. 2026. GuruFocus rates FRA:M6G with a GF Score™ of 55/100 and a GF Value™ of €12.85. The stock has 9 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Macerich Co's Research & Development for the three months ended in Mar. 2026 was €0.0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was €0.0 Mil.


Macerich Co  (FRA:M6G) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.


Macerich Co Research & Development Related Terms


Macerich Co Research & Development Historical Data

* Premium members only.

The historical data trend for Macerich Co's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Macerich Co Research & Development Chart

Macerich Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Macerich Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
FRA:M6G
55GF Score
Macerich Co FRA:M6G
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Macerich Co Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of €0.0 Mil mean?
Macerich Co (FRA:M6G) has a Research & Development of €0.0 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on Macerich Co and its competitors.
Is Macerich Co's Research & Development too high?
Macerich Co's current Research & Development is €0.0 Mil. Overall, Macerich Co has a GF Score™ of 55/100, reflecting its overall financial health beyond just this single metric.
How does Macerich Co's Research & Development compare to EPRT and KRG?
Macerich Co's Research & Development of €0.0 Mil can be compared against companies in the REITs industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a REITs company?
A good Research & Development depends on the REITs industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Macerich Co and its competitors. Macerich Co's current Research & Development is €0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Macerich Co stock overvalued right now?
Macerich Co (FRA:M6G) has a current Research & Development of €0.0 Mil. The stock's GF Value™ is €12.85, compared to a current price of €21.40 — trading 66.5% above its estimated fair value. The current Research & Development is €0.0 Mil. Macerich Co's overall GF Score™ is 55/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Macerich Co (FRA:M6G), the current Research & Development is €0.0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Macerich Co (FRA:M6G) Overvalued in 2026?

Based on GuruFocus' analysis, Macerich Co stock appears to be overvalued. The current stock price of €21.40 is trading 66.5% above its estimated GF Value™ of €12.85.

Key valuation signals for FRA:M6G:

  • Research & Development: €0.0 Mil
  • GF Value™: €12.85 vs. price of €21.40 (66.5% above fair value)
  • GF Score™: 55/100 with 9 warning signs

No single metric tells the full story. See the FRA:M6G stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Macerich Co Business Description

Industry Real EstateREITs
Other Exchanges MAC:USA0JX5:UKM6G:Germany
Address 401 Wilshire Boulevard, Suite 700, Santa Monica, CA, USA, 90401
Macerich invests in premium mall assets. The company owns 27 regional malls in its consolidated portfolio and 10 regional malls in its unconsolidated portfolio along with a power center and seven other real estate assets. The company's total portfolio has 39.9 million square feet of gross leasable area and averaged $867 sales per square foot over the 12 months ended in September 2025.
55GF Score

Get the complete analysis for FRA:M6G

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€21.40
Price
€12.85
GF Value